SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

EU to vaccinate ‘all who need’ by end of summer: official
4 March 2021
Two hundred nine US counties face a crisis in staffing ICUs that care for COVID-19 patients
4 March 2021

SARS-CoV-2 mutations can complicate immune surveillance of human T-killer cells

The body’s immune response plays a crucial role in the course of a SARS-CoV-2 infection. In addition to antibodies, the so-called T-killer cells, are also responsible for detecting viruses in the body and eliminating them. Scientists from the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna have now shown that SARS-CoV-2 can make itself unrecognizable to the immune response by T-killer cells through mutations. The findings of the research groups of Andreas Bergthaler, Judith Aberle and Johannes Huppa provide important clues for the further development of vaccines and were published in the journal Science Immunology.

Comments are closed.